SciClone Pharmaceuticals (Holdings) Limited
HKEX:6600.HK
18.72 (HKD) • At close June 20, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | ||||||||||||
| Net Income
| 1,217.397 | 940.08 | 1,025.873 | 816.809 | 661.171 | 495.273 | 260.514 | 213.364 | 191.289 | 156.34 | 66.376 | 59.964 |
| Depreciation & Amortization
| 145.515 | 118.897 | 107.846 | 113.61 | 36.373 | 35.829 | 34.915 | 6.839 | 6.045 | 5.284 | 5.206 | 21.499 |
| Deferred Income Tax
| 0 | 0 | -152.681 | -31.527 | -17.528 | -173.369 | -25.207 | 0 | 0 | 0 | 0 | 0 |
| Stock Based Compensation
| 66.967 | 52.343 | 63.013 | 66.823 | 34.041 | 7.592 | 54.598 | 44.667 | 28.833 | 21.49 | 24.258 | 24.291 |
| Change In Working Capital
| -90.099 | -234.148 | -46.828 | -2.862 | 328.551 | -193.401 | -165.215 | -5.839 | -1.084 | 8.838 | -60.691 | 7.212 |
| Accounts Receivables
| -86.992 | -234.45 | -221.721 | 26.771 | 265.389 | -193.294 | -129.111 | -16.699 | 1.987 | -20.318 | -24.21 | 2.219 |
| Inventory
| -174.376 | 27.651 | -13.087 | -41.058 | 7.503 | -1.481 | -37.096 | -20.837 | 9.297 | 33.379 | -28.363 | 4.993 |
| Accounts Payables
| 0 | 234.45 | 221.721 | -26.771 | -265.389 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Working Capital
| -44.024 | -261.799 | -33.741 | 38.196 | 321.048 | -191.92 | -128.119 | 31.697 | -12.368 | -4.224 | -8.118 | 0 |
| Other Non Cash Items
| -12.291 | 306.396 | 32.233 | 18.114 | -10.982 | -4.483 | -5.778 | -19.296 | -14.03 | -20.721 | 22.376 | 189.816 |
| Operating Cash Flow
| 1,404.279 | 1,183.568 | 1,029.456 | 980.967 | 1,031.626 | 167.441 | 153.827 | 239.735 | 211.052 | 171.231 | 57.525 | 271.279 |
| Investing Activities: | ||||||||||||
| Investments In Property Plant And Equipment
| -77.573 | -196.133 | -190.812 | -469.366 | -32.642 | -24.771 | -10.728 | -4.499 | -11.914 | -9.005 | -1.961 | -7.031 |
| Acquisitions Net
| 0 | 0 | -184.84 | -465.619 | 30.695 | 12.324 | 0 | 0 | 0 | 0 | 0 | 0 |
| Purchases Of Investments
| -1,560.065 | -4,929.18 | -1,207.171 | -1,060.98 | -626.976 | -13.726 | 0 | 0 | 0 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 2,145.877 | 4,099.316 | 1,109.326 | 1,022.84 | 507.128 | 127.455 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activites
| 512.709 | 0.448 | 347.26 | 302.496 | -30.695 | 73.429 | 6.024 | -18.872 | -46.584 | -29.466 | 2.294 | -0.467 |
| Investing Cash Flow
| 509.486 | -1,025.549 | -126.237 | -670.629 | -152.49 | 174.711 | -4.704 | -23.371 | -58.497 | -38.471 | 0.333 | -7.499 |
| Financing Activities: | ||||||||||||
| Debt Repayment
| -860.352 | -435.33 | -777.792 | -19.283 | -22.993 | -24.557 | -23.948 | 0 | 0 | 0 | 0 | 0 |
| Common Stock Issued
| 24.537 | 16.005 | 1,734.174 | 25.385 | 0 | 45.347 | 19.169 | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased
| -714.645 | -32.833 | 0 | 19.283 | 0 | 0 | -471.747 | 0 | -83.175 | -151.329 | -75.79 | -154.81 |
| Dividends Paid
| -215.018 | -205.622 | -827.303 | -2,173.758 | -211.596 | -563.419 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 18.701 | -12.482 | -13.51 | 2,095.033 | -22.993 | -24.557 | -23.948 | 12.901 | 28.515 | 22.29 | 25.221 | -153.956 |
| Financing Cash Flow
| -1,784.478 | -670.262 | 115.569 | -53.34 | -234.589 | -542.629 | -476.526 | 12.901 | -54.66 | -129.039 | -50.569 | -153.956 |
| Other Information: | ||||||||||||
| Effect Of Forex Changes On Cash
| 8.075 | 56.584 | -10.286 | -57.502 | -1.019 | -5.19 | 13.399 | -0.187 | 0.63 | -1.085 | 2.246 | -0.28 |
| Net Change In Cash
| 137.362 | -455.659 | 1,008.502 | 199.496 | 643.528 | -205.667 | -314.004 | 274.799 | 123.573 | 15.335 | 9.535 | 109.544 |
| Cash At End Of Period
| 1,809.191 | 1,671.829 | 2,127.488 | 1,118.986 | 919.49 | 275.962 | 481.629 | 933.158 | 658.359 | 534.786 | 519.451 | 525.018 |